Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
2021 · BMC Medicine · 64 citations
https://doi.org/10.1186/s12916-021-02031-3
H
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.3K
Citations
20
h-index
22
i10-index
Haohai Zhang is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cancer-related molecular mechanisms research & RNA modifications and cancer & Adenosine and Purinergic Signaling. The author has an h-index of 20, co-authored 30 publications.
ORCID: 0000-0002-5292-6505Papers by this author
worksA mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
2022 · Genome Medicine · 56 citations
https://doi.org/10.1186/s13073-022-01024-y
HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease
2018 · Journal of Autoimmunity · 51 citations
https://doi.org/10.1016/j.jaut.2018.07.022
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
2024 · BMC Medicine · 37 citations
https://doi.org/10.1186/s12916-024-03257-7
Lung cancer associated transcript 1 binds heat shock protein 90 to promote growth of hepatocellular carcinoma
2025 · Cellular Signalling · 1 citations
https://doi.org/10.1016/j.cellsig.2025.111671
Additional file 1 of A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.19227043
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat